-
US overtakes China with largest number of coronavirus cases
pharmaceutical-technology
March 30, 2020
The US now has more confirmed cases of novel coronavirus (Covid-19) than any other country with 85,996 cases, surpassing China and Italy.
-
Dynavax teams up with CEPI for Covid-19 vaccine
pharmaceutical-technology
March 30, 2020
Dynavax Technologies has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine against Covid-19 infection.
-
US researchers repurpose blood clots drug for Covid-19
pharmaceutical-technology
March 30, 2020
Researchers at Massachusetts Institute of Technology (MIT) and the University of Colorado at Denver in the US are working on repurposing an existing blood clots drug to help patients at risk of respiratory failure.
-
US researchers repurpose blood clots drug for Covid-19
pharmaceutical-technology
March 30, 2020
Researchers at Massachusetts Institute of Technology (MIT) and the University of Colorado at Denver in the US are working on repurposing an existing blood clots drug to help patients at risk of respiratory failure.
-
Bionova Scientific Introduces COVID-19 Support Program
contractpharma
March 30, 2020
To make lab capacity available to industry partners impacted by COVID-19 shutdowns.
-
BGI Genomics Receives EUA for SARS-CoV-2 Test Kit
contractpharma
March 30, 2020
Test can return results within three hours and is intended for the qualitative detection of the virus that causes COVID-19 disease.
-
Berkshire Sterile Manufacturing Fills Novel COVID-19 Treatments
contractpharma
March 30, 2020
For patients that develop severe lung problems in response to the coronavirus.
-
BioDuro to Develop COVID-19 Nanobody Therapeutic
contractpharma
March 30, 2020
Specialized COVID-19 team and technology assembled to accelerate discovery of new biologic.
-
Altasciences Completes Phase I Study in COVID-19 Patients
contractpharma
March 30, 2020
Gimsilumab, a monoclonal antibody, is being evaluated in patients with or at risk of developing acute respiratory distress syndrome.
-
NPPA to ensure unobstructed movement of pharma related goods across India
expresspharma
March 30, 2020
Pharma industry along with retail chemists, wholesalers, pharma C&F agents of drugs and medicines and other members associated with the supply chain faces problem in the movement of goods, during initial days of nationwide lockdown.